The global gastrointestinal endoscopy device market was valued at USD 54.2 billion in 2025. The market is projected to grow from USD 58.65 billion in 2026 to USD 103.03 billion by 2034, exhibiting a compound annual growth rate of 7.3% during the forecast period. Contrive Datum Insights presents this information in its report titled "Gastrointestinal Endoscopy Device Market Size, Share & Industry Analysis, By Product (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), Sales channel (Medical Stores & Brand Outlet, Online Retailing), End user (Hospitals, Ambulatory Surgical Center, Clinics & Dialysis Centers), Usage (Reusable, Single-Use (Disposable)), Application (Diagnostic, Therapeutic), and Regional Forecast, 2026-2034".
Gastrointestinal endoscopy devices are the videoscopes, imaging processors, biopsy and resection instruments, hemostasis tools and accessory devices used to visualize, diagnose and treat conditions of the esophagus, stomach, small bowel, colon and pancreatobiliary tract. The category spans reusable and single-use scopes, capsule-based imaging systems and the retrieval, sampling and closure instruments used alongside them during a procedure. Buyers are hospital gastroenterology and endoscopy departments, ambulatory surgical centers and specialty clinics that perform diagnostic screening and therapeutic interventional procedures.
Rising global burden of colorectal and GI cancers driving screening volumes
Rising global burden of colorectal and GI cancers driving screening volumes is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.3% a year, the product lines exposed to it move fastest: Capsule Endoscopy compounds at 10.2%, taking its share of revenue from 11% to 14% and its value from USD 5.96 billion to USD 14.42 billion.
On the upside, the study's bull case assumes faster than expected adoption of single-use endoscopes and accelerated screening-program rollouts in Asia Pacific lift procedure volumes above the base case, which would take 2034 revenue to USD 118.48 billion rather than the USD 103.03 billion base case.
However, slower hospital capital budgets and delayed screening-program funding in price-sensitive markets hold procedure volume growth below the base case, which would hold 2034 revenue to USD 91.7 billion. GI Videoscopes, which carries 31.99% of 2025 revenue, already grows at only 6.13% against the market's 7.3%, so the largest part of the base is also its slowest.
Key Players Compete on GI Videoscopes Volume and Capsule Endoscopy Growth
Competition in the global gastrointestinal endoscopy device market runs along the product axis rather than the regional one. GI Videoscopes holds 31.99% of 2025 revenue at USD 17.34 billion and remains the largest line through 2034 at 29.02%, making it the position hardest for a challenger to take. Capsule Endoscopy, growing at 10.2%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 54.2 billion.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Product | GI Videoscopes | 31.99% · USD 17.34 billion | — |
| Sales channel | Medical Stores & Brand Outlet | 81.99% · USD 44.44 billion | Online Retailing 10.88% |
| End user | Hospitals | 68.01% · USD 36.86 billion | Ambulatory Surgical Center 10.09% |
| Usage | Reusable | 71% · USD 38.48 billion | Single-Use (Disposable) 11.91% |
| Application | Diagnostic | 56% · USD 30.35 billion | Therapeutic 8.44% |
- Based on regional analysis, North America led the global gastrointestinal endoscopy device market in 2025 with 36.5% of global revenue at USD 19.79 billion, reaching USD 34 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 27% in 2025 to 32.5% in 2034, with revenue growing from USD 14.63 billion to USD 33.48 billion.
- Middle East and Africa remains the smallest region throughout, at 5.2% of 2025 revenue and 4.7% by 2034.
- Capsule Endoscopy is projected to grow at 10.2% over the forecast period, the fastest of any product line.
- The United States is the largest single country market at USD 17.42 billion in 2025, 32.14% of global revenue.
The report segments the market across five axes; by product, and by sales channel, end user, usage and application; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 91.7 billion and USD 118.48 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.